Ambrx Biopharma Inc.
USD28.00
+0.02 (+0.07%)
CEO
Daniel J. O'Connor
IPO Date
2023-08-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$27.99
Prev. Close
$27.98
Day Low
$27.98
Day High
$28.00
52W Low
$6.55
52W High
$28.15
Market Cap
$1.77B
Volume
1.42M
| -2.7 |
| 31 Dec 2020 | FY | 100.0% | -130.5% | 12.8% | -13.3% | -0.02 | 7.02 | -36.0 |
| 31 Dec 2019 | FY | 100.0% | -216.4% | -66.8% | -36.1% | 0.14 | 1.22 | -28.8 |
| -12.9 |
| 31 Mar 2023 | Q1 | 100.0% | -63758.3% | -8.4% | -7.3% | 0.06 | 10.13 | -6.6 |
| 31 Dec 2022 | Q4 | 100.0% | -590.4% | -11.2% | -9.0% | 0.10 | 5.44 | -1.7 |
| 30 Sept 2022 | Q3 | 100.0% | -590.4% | -11.2% | -9.0% | 0.00 | 5.44 | -0.8 |
| 30 Jun 2022 | Q2 | 100.0% | -2220.3% | -20.3% | -15.9% | 0.09 | 4.70 | -0.9 |
| 31 Mar 2022 | Q1 | 100.0% | -1404.0% | 0.0% | 0.0% | 0.00 | 0.00 | -1.8 |
| 31 Dec 2021 | Q4 | 100.0% | -1824.7% | -11.2% | -9.3% | 0.07 | 7.19 | -2.2 |
| 30 Sept 2021 | Q3 | 100.0% | -1681.8% | 0.0% | 0.0% | 0.00 | 0.00 | -6.6 |
| 30 Jun 2021 | Q2 | 100.0% | -565.3% | -7.5% | -6.8% | 0.01 | 9.90 | -0.9 |